Updated Jul 16, 2026
Neufeld Leah R is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $19K. Historical track record: 3/5 stars across 3 tracked purchases.
Leah R. Neufeld is the Chief People Officer at Immuneering Corp, a biopharmaceutical company focused on drug development for oncologic and neurologic diseases. She has held this role since the company's early stages, contributing to its growth and organizational development.
| Role | CHIEF PEOPLE OFFICER |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★☆☆ (3/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 6667% |
| 90-day win rate | 10000% |
| Avg 5-day return | +905.14% |
| Avg 30-day return | +728.08% |
| Avg 90-day return | +4621.71% |
| Best 30-day return | +1995.16% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-17 | IMRX | Immuneering Corp | A — Grant or award | 3.6K | $4.29 | $16K |
| 2026-01-15 | IMRX | Immuneering Corp | P — Open-market purchase | 2.6K | $4.15 | $11K |
| 2025-10-01 | IMRX | Immuneering Corp | P — Open-market purchase | 800 | $6.38 | $5K |
| 2025-09-15 | IMRX | Immuneering Corp | A — Grant or award | 11.8K | $1.43 | $17K |
| 2025-07-02 | IMRX | Immuneering Corp | P — Open-market purchase | 700 | $3.57 | $2K |
Leah R. Neufeld is the Chief People Officer at Immuneering Corp, a biopharmaceutical company focused on drug development for oncologic and neurologic diseases. She has held this role since the company's early stages, contributing to its growth and organizational development.…
Recorded transactions: 3 open-market purchases ($19K) and 0 open-market sales () across all tracked filings.
Across 3 tracked purchases, Neufeld Leah R averaged +728.1% avg 30-day return with a 6667% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Neufeld Leah R profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.